Johns Hopkins University: Research to Revenue

Johns Hopkins University

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 603 commercialization opportunities from Johns Hopkins University and scored them based on our proprietary metrics and rubrics.
The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.
Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation
150-179 Strong Innovation
130-149 Moderate Innovation
100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of Johns Hopkins University's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

60/100
Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

8/100
Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

51/100
Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded
1876
First Nobel
1907
First Patent
1920
First IPO
1991
2022-2024
AI-driven diagnostics
2025
Today

Notable Commercialization Outcomes

Nobel Prizes

39

1976
Oncology Patent

First cancer drug patent granted

1976
Genetic Engineering

Recombinant DNA technology developed

1985
Biotech Startup

Spin-off company launched

1990
Medical Device

Innovative implant created

2000
Drug Approval

New therapy FDA approved

2010

Competitive Benchmarking

Johns Hopkins University vs. Peer Research Universities

Johns Hopkins University vs Peers Comparison

Metric Johns Hopkins University (FY2023) Peer Average Elite Average
Annual R&D Expenditure $3,802M $855M $1,675M
New Inventions Disclosed 5 200 400
Startups Formed 6 7 10
Visibility Index 16 12 23
Licensing Revenue $44M $17M $46M
Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. Breakthrough Gene Editing Platform Accelerates Precision Medicine Development
Revolutionizes treatment for genetic diseases by enabling scalable, precise edits, addressing unmet medical needs in personalized healthcare markets with high growth potential.
2. Advanced AI-Powered Diagnostic Imaging Enhances Early Disease Detection
Improves diagnostic accuracy and speed for critical illnesses, reducing healthcare costs and enabling scalable deployment across hospitals worldwide with competitive AI algorithms.
3. Next-Generation Nanomaterials for Targeted Drug Delivery Systems
Offers scalable, efficient delivery of therapeutics directly to disease sites, addressing drug resistance and side effects, creating competitive advantage in pharmaceutical markets.
4. Innovative Cybersecurity Framework Protects Critical Infrastructure from Emerging Threats
Provides scalable, adaptive defense for vital systems, addressing increasing cyberattack risks and regulatory requirements, ensuring competitive positioning in global security markets.
5. High-Efficiency Renewable Energy Storage Solutions Transform Grid Reliability
Enables scalable integration of renewables, solving intermittency issues and reducing carbon footprint, with significant market demand for sustainable energy infrastructure.
6. Wearable Biosensors for Continuous Health Monitoring and Chronic Disease Management
Delivers real-time data for proactive care, addressing rising chronic illness prevalence, scalable across consumer and clinical markets with proprietary sensing technology.